PhD, Immunology and Microbial Pathogenesis, Thomas Jefferson University (2008)
BS, Pharmacology and Toxicology, University of the Sciences (2001)
Adam Snook, PhD
Associate Professor
Contact Information
Associate Professor
Education
Publications
- GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
- Biomarkers for Managing Neurodegenerative Diseases
- CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
- CD5 deletion enhances the antitumor activity of adoptive T cell therapies
- In vitro assays to evaluate CAR-T cell cytotoxicity
Expertise & Research Interests
My research has focused on the discovery and clinical development of novel cancer immunotherapeutics targeting the self/tumor antigen guanylyl cyclase C (GUCY2C; GCC). Please refer to my laboratory site for current research.